Looking for Rapid Antigen Test Kits? Click here.

Precision Medicine & Ion Channel Retreat 2017

Precision Medicine & Ion Channel Retreat 2017

Precision Medicine & ION Channel Retreat 2017 logo

Vancouver, British Columbia, Canada

August 9th – 11th, 2017

About Us

Aurora’s Ion Channel Retreat (ICR) began in 2003 and has since become one of the most recognized events for Ion Channel scientists to share ideas and connect with each other. Due to the success of the inaugural Precision Medicine & Ion Channel 2016 last year in Guangzhou, Aurora is proud to continue the joint topic retreat this year.

Aurora’s history and experience in hosting Ion Channel conferences can boost potential new research opportunities and innovations for Precision Medicine. The PM&ICR2017 will showcase Ion Transporter technology in Pathogenesis and Drug Discovery. Likewise, the Precision Medicine session will also be refocusing the topics towards Cancer Diagnosis and Treatment, Liquid Biopsy, Clinical Next Generation Sequencing (NGS) technology, Immunotherapy, and Biotechnology.


Precision Medicine Session

  1. Novel Perspective of Ion Channels in Precision Medicine
  2. Molecular Diagnostic Technologies
  3. Cancer Diagnosis and Treatment
  4. Liquid Biopsy in Oncology
  5. Liquid Biopsy for Clinical Practice
  6. Immunotherapy: emerging applications and challenges
  7. Applications of Next Generation Sequencing
  8. Microarray and Biotechnology

Ion Channel Session

  1. Ion Channel Structure and Function
  2. Ion Channels as Disease Targets
  3. Ion Channels as Pain Targets
  4. Drug Discovery & Drug Development
  5. Screening Technologies
  6. Cardiac Safety and the CiPA Initiative
  7. Ion Transporters in Pathogenesis
  8. Ion Transporters in Drug Discovery

Past Attendees

  • Craig January, MD, PhD – Professor at the School of Medicine and Public Health, at the University of Wisconsin
  • William Catterall, PhD – Professor and Chair of University of Washington Department of Pharmacology
  • Arthur Brown, PhD – CEO of MemChan; former founder & CEO of ChanTest
  • Yuko Sekino, PhD – Director of Pharmacology National Institute of Health Sciences, Japan
  • Edward Stevens, PhD – Head of Electrophysiology at Pfizer, Cambridge, UK
  • Dennis Lo, MD, PhD – Associate Dean, Faculty of Medicine at CUHK, Foreign Associate US Academy of Sciences
  • George Chandy, MD, PhD – Professor at NTU SG and UC Irvine
  • Kurt Stoeckli President & CSO at Glenmark Pharmaceuticals, Switzerland
  • Hailin Zhang, MD, PhD – Vice President of Hebei Medical University
  • Richard Olsen, PhDDistinguished Professor of Neuroscience at the David Geffen School of Medicine at UCLA
  • Yuklam Lo Secretariat, and Honorary Chairman, Hong Kong Biotechlogy Organization
  • An Hailong Hebei University of Technology; Professor
  • Dan Minor, PhD – Professor, Biochemistry and Biophysics, Cellular and Molecular Pharmacology, University of California
  • Steve Goldstein, MD, PhDDirector at the Institute of Pediatric Sciences, University of Chicago
  • John Dunlop, PhD VP, Neuroscience Research at Amgen, Professor of Neuroscience, University of St Andrews
  • Laszlo Urban, MD, PhD – Executive Director at Novartis
  • Jean-Pierre Valentin, PhD – Senior Director, Head of Investigative Toxicology at UCB

Corporate Sponsors

Diamond Sponsor


Bronze Sponsors

nanion logo
sb DrugDiscovery
MaxCyte logo

Program Sponsors

discovery from charles river logo
TetraGenetics logo

Media Sponsors

GEN Genetic Engineering & Biotechonology News logo
Genome British Columbia logo
Drug Discovery Development logo
LifeSciences British Columbia logo
The Journal of Precision Medicine logo